Glucometabolic outcomes of GLP-1 receptor agonist-based therapies in patients with type 2 diabetes: a systematic review and network meta-analysis

BACKGROUND: Innovative GLP-1 receptor agonist (GLP-1RA)-based treatment strategies—such as tirzepatide, GLP-1RA plus basal insulin fixed-ratio combinations [FRC], GLP-1RA plus sodium glucose cotransporter-2 inhibitors [SGLT-2i] combinations, and high-dose GLP-1RA—have been listed among the most effi...

Descripción completa

Detalles Bibliográficos
Autores principales: Caruso, Irene, Di Gioia, Ludovico, Di Molfetta, Sergio, Cignarelli, Angelo, Palmer, Suetonia Cressida, Natale, Patrizia, Strippoli, Giovanni F.M., Perrini, Sebastio, Natalicchio, Annalisa, Laviola, Luigi, Giorgino, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500557/
https://www.ncbi.nlm.nih.gov/pubmed/37719418
http://dx.doi.org/10.1016/j.eclinm.2023.102181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500557/
https://www.ncbi.nlm.nih.gov/pubmed/37719418
http://dx.doi.org/10.1016/j.eclinm.2023.102181

Ejemplares similares